CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.

Détails

Ressource 1Télécharger: REF.pdf (942.30 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_B3A5C856592D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
Périodique
Cardiovascular Research
Auteur⸱e⸱s
Mukhopadhyay P., Rajesh M., Bátkai S., Patel V., Kashiwaya Y., Liaudet L., Evgenov O.V., Mackie K., Haskó G., Pacher P.
ISSN
1755-3245[electronic], 0008-6363[linking]
Statut éditorial
Publié
Date de publication
2010
Volume
85
Numéro
4
Pages
773-784
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't Publication
Mots-clé
Amidohydrolases/metabolism, Animals, Antibiotics, Antineoplastic/toxicity, Apoptosis/physiology, Cardiomyopathies/chemically induced, Cardiomyopathies/metabolism, Caspase 3/metabolism, Caspase 7/metabolism, Cells, Cultured, Cytochromes c/metabolism, Disease Models, Animal, Doxorubicin/toxicity, Endocannabinoids/metabolism, Endomyocardial Fibrosis/chemically induced, Endomyocardial Fibrosis/metabolism, Humans, MAP Kinase Signaling System/physiology, Male, Mice, Mice, Knockout, Myocytes, Cardiac/cytology, Myocytes, Cardiac/metabolism, Oxidative Stress/physiology, Poly(ADP-ribose) Polymerases/metabolism, Reactive Nitrogen Species/metabolism, Reactive Oxygen Species/metabolism, Receptor, Cannabinoid, CB1/genetics, Receptor, Cannabinoid, CB1/metabolism, Ventricular Function, Left/physiology
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/03/2011 9:20
Dernière modification de la notice
14/02/2022 7:56
Données d'usage